High-resolution laser ablation-inductively coupled plasma-mass spectrometry imaging of cisplatin-induced nephrotoxic side effects

Analytica Chimica Acta

Volumn 945, Issue , 2016, Pages 23-30

  Van Acker, Thibaut ^a   Van Malderen, Stijn J M ^a   Van Heerden, Marjolein ^b   McDuffie, James Eric ^b   Cuyckens, Filip ^b   Vanhaecke, Frank ^a  

^a GHENT UNIVERSITY   (Belgium)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

Cisplatin; High resolution; Kidney; LA ICP MS; Mass spectrometry imaging

Indexed keywords

ABLATION; INDUCTIVELY COUPLED PLASMA; LASER ABLATION; MASS SPECTROMETERS;

CIS-PLATIN; HIGH RESOLUTION; KIDNEY; LA-ICP-MS; MASS-SPECTROMETRY IMAGING;

INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY;

CISPLATIN; ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALIBRATION; CELL DEATH; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GLOMERULUS; HIGH RESOLUTION LASER ABLATION INDUCTIVELY COUPLED PLASMA MASS; HISTOPATHOLOGY; KIDNEY CORTEX; KIDNEY INJURY; KIDNEY NECROSIS; KIDNEY OUTER MEDULLA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; MACACA FASCICULARIS; MALE; MASS SPECTROMETRY; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TISSUE SECTION; ANIMAL; DRUG EFFECTS; KIDNEY; LOW LEVEL LASER THERAPY; PROCEDURES;

ANIMALS; ANTINEOPLASTIC AGENTS; CALIBRATION; CISPLATIN; FEMALE; KIDNEY; LASER THERAPY; MACACA FASCICULARIS; MALE; MASS SPECTROMETRY;

EID: 84992724483     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2016.10.014     Document Type: Article

References (63)

1. [1] Rabik, C.A., Dolan, M.E., Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat. Rev. 33 (2007), 9–23.
2. [2] Wang, D., Lippard, S.J., Cellular processing of platinum anticancer drugs. Nat. Rev. Drug Discov. 4 (2005), 307–320.
3. [3] Oh, G.-S., Kim, H.J., Shen, A., Bin Lee, S., Khadka, D., Pandit, A., So, H.S., Cisplatin-induced kidney dysfunction and perspectives on improving treatment strategies. Electrolyte Blood Press 12 (2014), 55–65.
4. [4] Pabla, N., Dong, Z., Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 73 (2008), 994–1007.
5. [5] Schetz, M., Dasta, J., Goldstein, S., Golper, T., Drug-induced acute kidney injury. Curr. Opin. Crit. Care 11 (2005), 555–565.
6. [6] Benjamin, A., da Costa, A.N., Delaunois, A., Rosseels, M.-L., Valentin, J.-P., Renal safety pharmacology in drug discovery and development. Pugsley, M.K., Curtis, M.J., (eds.) Principles of Safety Pharmacology, first ed., 2015, Springer, Berlin Heidelberg, 323–352.
7. [7] Waring, M.J., Arrowsmith, J., Leach, A.R., Leeson, P.D., Mandrell, S., Owen, R.M., Pairaudeau, G., Pennie, W.D., Pickett, S.D., Wang, J., Wallace, O., Weir, A., An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nat. Rev. Drug Discov. 14 (2015), 475–486.
8. [8] Luyckx, V.A., Naicker, S., Acute kidney injury associated with the use of traditional medicines. Nat. Rev. Nephrol. 4 (2008), 664–671.
9. [9] Cepeda, V., Fuertes, M.A., Castilla, J., Alonso, C., Quevedo, C., Pérez, J.M., Biochemical mechanisms of cisplatin cytotoxicity. Anticancer. Agents Med. Chem. 7 (2007), 3–18.
10. [10] Eaton, D.C., Pooler, J.P., Renal functions, basic processes, and anatomy. Eaton, D.C., Pooler, J.P., (eds.) Vander's Renal Physiology, eighth ed., 2013, McGraw-Hill, New York, 1–19.
11. [11] Mescher, A.L., The urinary system. Mescher, A.L., (eds.) Junqueira's Basic Histology: Text & Atlas, thirteenth ed., 2013, McGraw-Hill, New York, 385–403.
12. [12] Kriz, W., Bankir, L., A standard nomenclature for structures of the kidney. Kidney Int. 33 (1988), 1–7.
13. [13] Esteban-Fernández, D., Moreno-Gordaliza, E., Cañas, B., Palacios, M.A., Gómez-Gómez, M.M., Analytical methodologies for metallomics studies of antitumor Pt-containing drugs. Metallomics 2 (2010), 19–38.
14. +/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agents. Biochem. Pharmacol. 81 (2011), 563–568.
15. [15] Yao, X., Panichpisal, K., Kurtzman, N., Nugent, K., Cisplatin nephrotoxicity: a review. Am. J. Med. Sci. 334 (2007), 115–124.
16. [16] Wang, S., Brown, R., Gray, D.J., Application of laser ablation-ICPMS to the spatially resolved micro-analysis of biological tissue. Appl. Spectrosc. 48 (1994), 1321–1325.
17. [17] Hare, D.J., George, J.L., Grimm, R., Wilkins, S., Adlard, P.A., Cherny, R.A., Bush, A.I., Finkelstein, D.I., Doble, P., Three-dimensional elemental bio-imaging of Fe, Zn, Cu, Mn and P in a 6-hydroxydopamine lesioned mouse brain. Metallomics 2 (2010), 745–753.
18. [18] Matusch, A., Depboylu, C., Palm, C., Wu, B., Höglinger, G.U., Schäfer, M.K.-H., Becker, J.S., Cerebral bioimaging of Cu, Fe, Zn, and Mn in the MPTP mouse model of Parkinson's disease using laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS). J. Am. Soc. Mass Spectrom. 21 (2010), 161–171.
19. [19] Becker, J.S., Breuer, U., Hsieh, H.-F., Osterholt, T., Kumtabtim, U., Wu, B., Matusch, A., Caruso, J.A., Qin, Z., Bioimaging of metals and biomolecules in mouse heart by laser ablation inductively coupled plasma mass spectrometry and secondary ion mass spectrometry. Anal. Chem. 82 (2010), 9528–9533.
20. [20] Becker, J.S., Kumtabtim, U., Wu, B., Steinacker, P., Otto, M., Matusch, A., Mass spectrometry imaging (MSI) of metals in mouse spinal cord by laser ablation ICP-MS. Metallomics 4 (2012), 284–288.
21. [21] Becker, J.S., Zoriy, M.V., Pickhardt, C., Palomero-Gallagher, N., Zilles, K., Imaging of copper, zinc, and other elements in thin section of human brain samples (hippocampus) by laser ablation inductively coupled plasma mass spectrometry. Anal. Chem. 77 (2005), 3208–3216.
22. [22] Hare, D., Tolmachev, S., James, A., Bishop, D., Austin, C., Fryer, F., Doble, P., Elemental bio-imaging of thorium, uranium, and plutonium in tissues from occupationally exposed former nuclear workers. Anal. Chem. 82 (2010), 3176–3182.
23. [23] Hare, D., Burger, F., Austin, C., Fryer, F., Grimm, R., Reedy, B., Scolyer, R.A., Thompson, J.F., Doble, P., Elemental bio-imaging of melanoma in lymph node biopsies. Analyst 134 (2009), 450–453.
24. [24] Vašinová Galiová, M., Čopjaková, R., Škoda, R., Štěpánková, K., Vaňková, M., Kuta, J., Prokeš, L., Kynický, J., Kanický, V., 2D elemental mapping of sections of human kidney stones using laser ablation inductively-coupled plasma-mass spectrometry: possibilities and limitations. Spectrochim. Acta Part B At. Spectrosc. 100 (2014), 105–115.
25. [25] Waentig, L., Techritz, S., Jakubowski, N., Roos, P.H., A multi-parametric microarray for protein profiling: simultaneous analysis of 8 different cytochromes via differentially element tagged antibodies and laser ablation ICP-MS. Analyst 138 (2013), 6309–6315.
26. [26] Managh, A.J., Hutchinson, R.W., Riquelme, P., Broichhausen, C., Wege, A.K., Ritter, U., Ahrens, N., Koehl, G.E., Walter, L., Florian, C., Schlitt, H.J., Reid, H.J., Geissler, E.K., Sharp, B.L., Hutchinson, J.A., Laser ablation-inductively coupled plasma mass spectrometry: an emerging technology for detecting rare cells in tissue sections. J. Immunol. 193 (2014), 2600–2608.
27. [27] Hutchinson, R.W., Cox, A.G., McLeod, C.W., Marshall, P.S., Harper, A., Dawson, E.L., Howlett, D.R., Imaging and spatial distribution of β-amyloid peptide and metal ions in Alzheimer's plaques by laser ablation–inductively coupled plasma–mass spectrometry. Anal. Biochem. 346 (2005), 225–233.
28. [28] Waentig, L., Jakubowski, N., Hardt, S., Scheler, C., Roos, P.H., Linscheid, M.W., Comparison of different chelates for lanthanide labeling of antibodies and application in a Western blot immunoassay combined with detection by laser ablation (LA-)ICP-MS. J. Anal. At. Spectrom. 27 (2012), 1311–1320.
29. [29] de Bang, T.C., Pedas, P., Schjoerring, J.K., Jensen, P.E., Husted, S., Multiplexed quantification of plant thylakoid proteins on Western blots using lanthanide-labeled antibodies and laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS). Anal. Chem. 85 (2013), 5047–5054.
30. [30] Giesen, C., Mairinger, T., Khoury, L., Waentig, L., Jakubowski, N., Panne, U., Multiplexed immunohistochemical detection of tumor markers in breast cancer tissue using laser ablation inductively coupled plasma mass spectrometry. Anal. Chem. 83 (2011), 8177–8183.
31. [31] Giesen, C., Wang, H.A.O., Schapiro, D., Zivanovic, N., Jacobs, A., Hattendorf, B., Schüffler, P.J., Grolimund, D., Buhmann, J.M., Brandt, S., Varga, Z., Wild, P.J., Günther, D., Bodenmiller, B., Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat. Methods 11 (2014), 417–422.
32. [32] Egger, A.E., Theiner, S., Kornauth, C., Heffeter, P., Berger, W., Keppler, B.K., Hartinger, C.G., Quantitative bioimaging by LA-ICP-MS: a methodological study on the distribution of Pt and Ru in viscera originating from cisplatin- and KP1339-treated mice. Metallomics 6 (2014), 1616–1625.
33. [33] Egger, A.E., Kornauth, C., Haslik, W., Hann, S., Theiner, S., Bayer, G., Hartinger, C.G., Keppler, B.K., Pluschnig, U., Mader, R.M., Extravasation of Pt-based chemotherapeutics – bioimaging of their distribution in resectates using laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS). Metallomics 7 (2015), 508–515.
34. [34] Gholap, D., Verhulst, J., Ceelen, W., Vanhaecke, F., Use of pneumatic nebulization and laser ablation–inductively coupled plasma–mass spectrometry to study the distribution and bioavailability of an intraperitoneally administered Pt-containing chemotherapeutic drug. Anal. Bioanal. Chem. 402 (2012), 2121–2129.
35. [35] Köppen, C., Reifschneider, O., Castanheira, I., Sperling, M., Karst, U., Ciarimboli, G., Quantitative imaging of platinum based on laser ablation-inductively coupled plasma-mass spectrometry to investigate toxic side effects of Cisplatin. Metallomics 7 (2015), 1595–1603.
36. [36] Moreno-Gordaliza, E., Giesen, C., Lázaro, A., Esteban-Fernández, D., Humanes, B., Cañas, B., Panne, U., Tejedor, A., Jakubowski, N., Gómez-Gómez, M.M., Elemental bioimaging in kidney by LA-ICP-MS as a tool to study nephrotoxicity and renal protective strategies in cisplatin therapies. Anal. Chem. 83 (2011), 7933–7940.
37. [37] Bianga, J., Bouslimani, A., Bec, N., Quenet, F., Mounicou, S., Szpunar, J., Bouyssiere, B., Lobinski, R., Larroque, C., Complementarity of MALDI and LA ICP mass spectrometry for platinum anticancer imaging in human tumor. Metallomics 6 (2014), 1382–1386.
38. [38] Bonta, M., Lohninger, H., Laszlo, V., Hegedus, B., Limbeck, A., Quantitative LA-ICP-MS imaging of platinum in chemotherapy treated human malignant pleural mesothelioma samples using printed patterns as standard. J. Anal. At. Spectrom. 29 (2014), 2159–2167.
39. [39] Pozebon, D., Dressler, V.L., Matusch, A., Becker, J.S., Monitoring of platinum in a single hair by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) after cisplatin treatment for cancer. Int. J. Mass Spectrom. 272 (2008), 57–62.
40. [40] Herdering, C., Wehe, C.A., Reifschneider, O., Raj, I., Ciarimboli, G., Diebold, K., Becker, C., Sperling, M., Karst, U., Laser ablation based bioimaging with simultaneous elemental and molecular mass spectrometry: towards spatially resolved speciation analysis. Rapid Commun. Mass Spectrom. 27 (2013), 2588–2594.
41. [41] Zoriy, M., Matusch, A., Spruss, T., Becker, J.S., Laser ablation inductively coupled plasma mass spectrometry for imaging of copper, zinc, and platinum in thin sections of a kidney from a mouse treated with cis-platin. Int. J. Mass Spectrom. 260 (2007), 102–106.
42. [42] Reifschneider, O., Wehe, C.A., Raj, I., Ehmcke, J., Ciarimboli, G., Sperling, M., Karst, U., Quantitative bioimaging of platinum in polymer embedded mouse organs using laser ablation ICP-MS. Metallomics 5 (2013), 1440–1447.
43. [43] Miliszkiewicz, N., Walas, S., Tobiasz, A., Current approaches to calibration of LA-ICP-MS analysis. J. Anal. At. Spectrom. 30 (2015), 327–338.
44. [44] Pozebon, D., Scheffler, G.L., Dressler, V.L., Nunes, M.A.G., Review of the applications of laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) to the analysis of biological samples. J. Anal. At. Spectrom. 29 (2014), 2204–2228.
45. [45] Günther, D., Hattendorf, B., Solid sample analysis using laser ablation inductively coupled plasma mass spectrometry. Trends Anal. Chem. 24 (2005), 255–265.
46. [46] Limbeck, A., Galler, P., Bonta, M., Bauer, G., Nischkauer, W., Vanhaecke, F., Recent advances in quantitative LA-ICP-MS analysis: challenges and solutions in the life sciences and environmental chemistry. Anal. Bioanal. Chem. 407 (2015), 6593–6617.
47. [47] Pugh, J.A.T., Cox, A.G., McLeod, C.W., Bunch, J., Whitby, B., Gordon, B., Kalber, T., White, E., A novel calibration strategy for analysis and imaging of biological thin sections by laser ablation inductively coupled plasma mass spectrometry. J. Anal. At. Spectrom. 26 (2011), 1667–1673.
48. [48] Austin, C., Hare, D., Rawling, T., McDonagh, A.M., Doble, P., Quantification method for elemental bio-imaging by LA-ICP-MS using metal spiked PMMA films. J. Anal. At. Spectrom. 25 (2010), 722–725.
49. [49] Bellis, D.J., Santamaria-Fernandez, R., Ink jet patterns as model samples for the development of LA-ICP-SFMS methodology for mapping of elemental distribution with reference to biological samples. J. Anal. At. Spectrom. 25 (2010), 957–963.
50. [50] Hoesl, S., Neumann, B., Techritz, S., Linscheid, M., Theuring, F., Scheler, C., Jakubowski, N., Mueller, L., Development of a calibration and standardization procedure for LA-ICP-MS using a conventional ink-jet printer for quantification of proteins in electro- and Western-blot assays. J. Anal. At. Spectrom. 29 (2014), 1282–1291.
51. [51] Hoesl, S., Neumann, B., Techritz, S., Sauter, G., Simon, R., Schlüter, H., Linscheid, M.W., Theuring, F., Jakubowski, N., Mueller, L., Internal standardization of LA-ICP-MS immuno imaging via printing of universal metal spiked inks onto tissue sections. J. Anal. At. Spectrom. 31 (2016), 801–808.
52. [52] Moraleja, I., Esteban-Fernández, D., Lázaro, A., Humanes, B., Neumann, B., Tejedor, A., Mena, M.L., Jakubowski, N., Gómez-Gómez, M.M., Printing metal-spiked inks for LA-ICP-MS bioimaging internal standardization: comparison of the different nephrotoxic behavior of cisplatin, carboplatin, and oxaliplatin. Anal. Bioanal. Chem. 408 (2016), 2309–2318.
53. [53] Nischkauer, W., Vanhaecke, F., Bernacchi, S., Herwig, C., Limbeck, A., Radial line-scans as representative sampling strategy in dried-droplet laser ablation of liquid samples deposited on pre-cut filter paper disks. Spectrochim. Acta Part B At. Spectrosc. 101 (2014), 123–129.
54. [54] Izmer, A., Gholap, D., De Houwer, K., Cuyckens, F., Vanhaecke, F., A pilot study on the use of laser ablation-ICP-mass spectrometry for assessing/mapping the distribution of a drug and its metabolites across the body compartments of rats. J. Anal. At. Spectrom. 27 (2012), 413–418.
55. [55] Birka, M., Wentker, K.S., Lusmöller, E., Arheilger, B., Wehe, C.A., Sperling, M., Stadler, R., Karst, U., Diagnosis of nephrogenic systemic fibrosis by means of elemental bioimaging and speciation analysis. Anal. Chem. 87 (2015), 3321–3328.
56. [56] Niehoff, A.-C., Bauer, O.B., Kröger, S., Fingerhut, S., Schulz, J., Meyer, S., Sperling, M., Jeibmann, A., Schwerdtle, T., Karst, U., Quantitative bioimaging to investigate the uptake of mercury species in Drosophila melanogaster. Anal. Chem. 87 (2015), 10392–10396.
57. [57] Teledyne CETAC Technologies, Aerosol Rapid Introduction System (ARIS). 2016 http://www.teledynecetac.com/product/laser-ablation/aris (Accessed 7 June 2016).
58. [58] Legin, A.A., Theiner, S., Schintlmeister, A., Reipert, S., Heffeter, P., Jakupec, M.A., Mayr, J., Varbanov, H.P., Kowol, C.R., Galanski, M., Berger, W., Wagner, M., Keppler, B.K., Multi-scale imaging of anticancer platinum(IV) compounds in murine tumor and kidney. Chem. Sci. 7 (2016), 3052–3061.
59. [59] Luisier, F., High-quality Denoising of Multidimensional Fluorescence Microscopy Images. 2014 http://bigwww.epfl.ch/algorithms/denoise/#ref (Accessed 12 September 2016).
60. [60] Lemley, K.V., Kriz, W., Anatomy of the renal interstitium. Kidney Int. 39 (1991), 370–381.
61. [61] Ferrero-Miliani, L., Nielsen, O.H., Andersen, P.S., Girardin, S.E., Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1β generation. Clin. Exp. Immunol. 147 (2007), 227–235.
62. [62] Majno, G., Joris, I., Apoptosis, oncosis, and necrosis. An overview of cell death. Am. J. Pathol. 146 (1995), 3–15.
63. [63] Kumar, S., Muchmore, A., Tamm-Horsfall protein—uromodulin (1950–1990). Kidney Int. 37 (1990), 1395–1401.